TAS-102 and the quest for predictive biomarkers

Por van der Velden, Daphne L, Opdam, Frans L, Opdam, Frans L
Publicado no ESMO Open (2017)

Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape

Por Oosting, Sjoukje F, Fehrmann, Rudolf S, de Vries, Elisabeth G E
Publicado no ESMO Open (2017)

Liquid biopsy for HER2-positive breast cancer brain metastasis: the role of the cerebrospinal fluid

Por De Mattos-Arruda, Leticia
Publicado no ESMO Open (2017)

Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy

Por Dolly, Saoirse O, Migali, Cristina, Tunariu, Nina, Della-Pepa, Chiara, Khakoo, Shelize, Hazell, Steve, de Bono, Johann S, Kaye, Stanley B, Banerjee, Susana
Publicado no ESMO Open (2017)

Between January 2009 and April 2016, 134 novel anticancer therapies were approved: what is the level of knowledge concerning the clinical benefit at the time of approval?

Por Grössmann, Nicole, Wild, Claudia
Publicado no ESMO Open (2017)

Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor

Por Koo, Dong-Hoe, Ryu, Min-Hee, Kim, Kyoung-Mee, Yang, Han-Kwang, Sawaki, Akira, Hirota, Seiichi, Zheng, Jie, Zhang, Bo, Tzen, Chin-Yuan, Yeh, Chun-Nan, Nishida, Toshirou, Shen, Lin, Chen, Li-Tzong, Kang, Yoon-Koo
Publicado no Cancer Res Treat (2016)

Back to the ‘essence’ of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines

Por Eniu, Alexandru, Torode, Julie, Magrini, Nicola, Bricalli, Gracemarie
Publicado no ESMO Open (2016)

Cancer immune cycle: a video introduction to the interaction between cancer and the immune system

Por Preusser, Matthias, Berghoff, Anna S, Thallinger, Christiane, Zielinski, Christoph C
Publicado no ESMO Open (2016)

Single institution long-term efficacy and safety analysis of abiraterone acetate (AA) in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) in a...

Por Fröbe, Ana, Murgić, Jure, Rauh, Stefan
Publicado no ESMO Open (2016)

Quality to rely on: meeting report of the 5th Meeting of External Quality Assessment, Naples 2016

Por van Krieken, Han, Deans, Sandi, Hall, Jacqueline A, Normanno, Nicola, Ciardiello, Fortunato, Douillard, Jean-Yves
Publicado no ESMO Open (2016)

Specific CDK4/6 inhibition in breast cancer: a systematic review of current clinical evidence

Por Polk, Anne, Kolmos, Ida Lykke, Kümler, Iben, Nielsen, Dorte Lisbeth
Publicado no ESMO Open (2017)

Prevalence of hypothyroidism among patients with breast cancer treated with radiation to the supraclavicular field: a single-centre survey

Por Kikawa, Yuichiro, Kosaka, Yasuhiro, Hashimoto, Kazuki, Hohokabe, Eri, Takebe, Sayaka, Narukami, Ryo, Hattori, Takayuki, Ueki, Kazuhiro, Ogura, Kengo, Imagumbai, Toshiyuki, Kato, Hironori, Kokubo, Masaki
Publicado no ESMO Open (2017)

Impact of intervention aimed at improving the integration of oncology units and local palliative care services: results of the multicentre prospective sequential MIRTO study

Por Martoni, Andrea A, Melotti, Barbara, Degli Esposti, Claudia, Mutri, Vita, Lelli, Giorgio, Ansaloni, Silvia, Piva, Erico, Strocchi, Elena, Pannuti, Franco
Publicado no ESMO Open (2017)

European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer

Por Stanel, Stefan Cristian, Sjöberg, Jan, Salmonson, Tomas, Foggi, Paolo, Caleno, Mariapaola, Melchiorri, Daniela, Gravanis, Iordanis, Tzogani, Kyriaki, Pignatti, Francesco
Publicado no ESMO Open (2017)

Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantation

Por Sharma, Atul, Tilak, TVSVGK, Bakhshi, Sameer, Raina, Vinod, Kumar, Lalit, Chaudhary, Surendra Pal, Sahoo, Ranjit Kumar, Gupta, Ritu, Thulkar, Sanjay
Publicado no ESMO Open (2017)

From precision medicine to cancer care through the immunome: highlights from the European Society of Medical Oncology Congress, Madrid, 26–30th September 2014

Por Curigliano, Giuseppe
Publicado em 2014

Computational prediction of multidisciplinary team decision-making for adjuvant breast cancer drug therapies: a machine learning approach

Por Lin, Frank P. Y., Pokorny, Adrian, Teng, Christina, Dear, Rachel, Epstein, Richard J.
Publicado no BMC Cancer (2016)

Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer

Por Sartore-Bianchi, Andrea, Valtorta, Emanuele, Amatu, Alessio, Veronese, Silvio, Lauricella, Calogero, Bonazzina, Erica, Siravegna, Giulia, Truini, Mauro, Bardelli, Alberto, Siena, Salvatore
Publicado no ESMO Open (2016)

Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancer

Por Gaschler-Markefski, Birgit, Sikken, Patricia, Heymach, John V, Gottfried, Maya, Mellemgaard, Anders, Novello, Silvia, Gann, Claudia-Nanette, Barrueco, José, Reck, Martin, Hanna, Nasser H, Kaiser, Rolf
Publicado no ESMO Open (2017)

Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer

Por Kitano, Atsuko, Ono, Makiko, Yoshida, Masayuki, Noguchi, Emi, Shimomura, Akihiko, Shimoi, Tatsunori, Kodaira, Makoto, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Kinoshita, Takayuki, Fujiwara, Yasuhiro, Tsuda, Hitoshi, Tamura, Kenji
Publicado no ESMO Open (2017)